References
- Veroniki AA, Cogo E, Rios P, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017;15(1):95.
- Viale L, Allotey J, Cheong-See F, et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015;386(10006):1845–1852.
- Hessler A, Dolbec K. ACOG clinical updates in women’s health care. [cited 2022 Jan 25]. Available from: https://www.acog.org/-/media/project/acog/acogorg/clinical/files/clinical-updates/2021/01/seizures.pdf
- Patel SI, Pennell PB. Management of epilepsy during pregnancy: an update. Ther Adv Neurol Disord. 2016;9(2):118–129.
- Hehir MP, D’Alton ME. Epilepsy in women during pregnancy. Lancet. 2016;387(10019):645–646.
- Borgelt LM, Hart FM, Bainbridge JL. Epilepsy during pregnancy: focus on management strategies. Int J Womens Health. 2016;8:505–517.
- Royal College of Obstetricians and Gynaecologists. Epilepsy in pregnancy. Green-top guideline no.68. June 2016. [cited 2020 Feb 24]. Available from: https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg68_epilepsy.pdf
- The Truven Health MarketScan databases for life sciences researchers. [cited 2021 Feb 15]. Available from: https://truvenhealth.com/Portals/0/Assets/2017-MarketScan-Databases-Life-Sciences-Researchers-WP.pdf
- Margulis AV, Setoguchi S, Mittleman MA, et al. Algorithms to estimate the beginning of pregnancy in administrative databases. Pharmacoepidemiol Drug Saf. 2013;22(1):16–24.